Product Information
MIRABEGRON ER 25 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $9.4332 per EA under NDC 70710115903. Its NADAC has been published 102 times since Jul 17, 2024.
Strength
25 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710115903
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MIRABEGRONApproval Type
Generic (ANDA)
FDA Application
ANDA209488On Market Since
1/23/2024
Pharmacological Classes
Price Statistics
The NADAC for MIRABEGRON ER 25 MG TABLET has been published 102 times since Jul 17, 2024, and over the history we have for it it has risen 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.4332 per EA |
|---|---|
| All-time high | $10.9668 (Sep 11, 2024) |
| All-time low | $8.0956 (Jul 17, 2024) |
| 52-week high | $10.2877 |
| 52-week low | $9.3185 |
| Median price | $9.9873 |
| Average price | $9.8513 |
| Largest weekly change | +35.5% (Aug 21, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MIRABEGRON ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 25 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $9.4332 per EA (NDC 70710115903), effective Jun 24, 2026.
How has the price of MIRABEGRON ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRABEGRON ER 25 MG TABLET has risen 16.5%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 25 MG TABLET?
Since Jul 17, 2024, the NADAC for MIRABEGRON ER 25 MG TABLET has ranged from a low of $8.0956 (Jul 17, 2024) to a high of $10.9668 (Sep 11, 2024), with a median of $9.9873 per EA.
Are there cheaper alternatives to MIRABEGRON ER 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MIRABEGRON ER 25 MG TABLET, but none are currently priced below it.
Who manufactures MIRABEGRON ER 25 MG TABLET?
MIRABEGRON ER 25 MG TABLET (NDC 70710115903) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification